ID   EN-1078D
AC   CVCL_A423
SY   EN1078D; En1078D
DR   Cosmic; 1576454
DR   Wikidata; Q54832306
RX   PubMed=17894888;
RX   PubMed=28196595;
WW   https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 14.3 hours (Note=At 13th passage), 13.8 hours (Note=At 23th passage) (PubMed=17894888).
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson A.-M.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 9,13
ST   D7S820: 8,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=17894888; DOI=10.1186/1477-7827-5-38;
RA   Dery M.-C., Van Themsche C., Provencher D.M., Mes-Masson A.-M.,
RA   Asselin E.;
RT   "Characterization of EN-1078D, a poorly differentiated human
RT   endometrial carcinoma cell line: a novel tool to study endometrial
RT   invasion in vitro.";
RL   Reprod. Biol. Endocrinol. 5:38.1-38.14(2007).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//